These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36727626)

  • 21. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
    Zhang DW; Wu HY; Zhu CR; Wu DD
    Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
    Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
    J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APE1 promotes proliferation and migration of cutaneous squamous cell carcinoma.
    Deng X; Zhen P; Niu X; Dai Y; Wang Y; Zhou M
    J Dermatol Sci; 2020 Oct; 100(1):67-74. PubMed ID: 32951990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression analysis and biological regulation of silencing regulatory protein 6 (SIRT6) in cutaneous squamous cell carcinoma.
    Chen S; Chen H; Wang X; Zhang D; Zhang L; Cheng J; Zhang Q; Hua Z; Miao X; Shi J
    An Bras Dermatol; 2024; 99(4):535-545. PubMed ID: 38548549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
    Zou S; Gao Y; Zhang S
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circ-LARP1B contributes to cutaneous squamous cell carcinoma progression by targeting microRNA-515-5p/TPX2 microtubule nucleation factor axis.
    Wang L; Hou S; Li J; Tian T; Hu R; Yu N
    Bioengineered; 2022 Jan; 13(1):1209-1223. PubMed ID: 34982022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53.
    Wang L; Xu L; Wang Y
    Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway.
    Zhu J; Hu H; Wang J; Yang Y; Yi P
    Cell Physiol Biochem; 2018; 49(2):696-705. PubMed ID: 30165366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proline-rich protein 11 silencing inhibits hepatocellular carcinoma growth and epithelial-mesenchymal transition through β-catenin signaling.
    Qiao W; Wang H; Zhang X; Luo K
    Gene; 2019 Jan; 681():7-14. PubMed ID: 30248355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53-Regulated Long Noncoding RNA PRECSIT Promotes Progression of Cutaneous Squamous Cell Carcinoma via STAT3 Signaling.
    Piipponen M; Nissinen L; Riihilä P; Farshchian M; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
    Am J Pathol; 2020 Feb; 190(2):503-517. PubMed ID: 31837949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transglutaminase 3 regulates cutaneous squamous carcinoma differentiation and inhibits progression via PI3K-AKT signaling pathway-mediated Keratin 14 degradation.
    Zhou K; Wu C; Cheng W; Zhang B; Wei R; Cheng D; Li Y; Cao Y; Zhang W; Yao Z; Zhang X
    Cell Death Dis; 2024 Apr; 15(4):252. PubMed ID: 38589352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
    Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
    Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.
    Farsam V; Basu A; Gatzka M; Treiber N; Schneider LA; Mulaw MA; Lucas T; Kochanek S; Dummer R; Levesque MP; Wlaschek M; Scharffetter-Kochanek K
    Oncotarget; 2016 Dec; 7(50):83554-83569. PubMed ID: 27907906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HSP105 suppresses the progression of cutaneous squamous cell carcinoma by activating the P53 signaling pathway.
    Jia M; Zhou KY; Deng LJ; Fang S
    Am J Cancer Res; 2023; 13(7):3013-3026. PubMed ID: 37559974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
    Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
    Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma.
    Zhang Y; Gao L; Ma S; Ma J; Wang Y; Li S; Hu X; Han S; Zhou M; Zhou L; Ding Z
    Cell Death Differ; 2019 Oct; 26(10):2061-2073. PubMed ID: 30683916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.
    Viiklepp K; Nissinen L; Ojalill M; Riihilä P; Kallajoki M; Meri S; Heino J; Kähäri VM
    J Invest Dermatol; 2022 May; 142(5):1478-1488.e9. PubMed ID: 34756877
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement factor I promotes progression of cutaneous squamous cell carcinoma.
    Riihilä P; Nissinen L; Farshchian M; Kivisaari A; Ala-Aho R; Kallajoki M; Grénman R; Meri S; Peltonen S; Peltonen J; Kähäri VM
    J Invest Dermatol; 2015 Feb; 135(2):579-588. PubMed ID: 25184960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.